FYI: Harvard-Led Study Finds 44.2% of GLP-1 Users Report Drinking Less #GLP1 #HarvardStudy #DrinkLess #HealthResearch #MedicationImpact
Harvard-Led Study Finds 44.2% of GLP-1 Users Report Drinking Less
In the self-reported survey, 54.1% of at-risk drinkers said they drank less after starting the medication
www.vinetur.com
November 8, 2026 at 2:07 PM
FYI: Harvard-Led Study Finds 44.2% of GLP-1 Users Report Drinking Less #GLP1 #HarvardStudy #DrinkLess #HealthResearch #MedicationImpact
Weight-Loss Drugs Like Ozempic May Come With an Unexpected Cost #Science #HealthandMedicine #PublicHealth #WeightLoss #HealthRisks #MedicationImpact
https://scitechdaily.com/weight-loss-drugs-like-ozempic-may-come-with-an-unexpected-cost/
https://scitechdaily.com/weight-loss-drugs-like-ozempic-may-come-with-an-unexpected-cost/
Weight-Loss Drugs Like Ozempic May Come With an Unexpected Cost
New research suggests that the promise of GLP-1 weight loss drugs is accompanied by an overlooked challenge: shifting, and sometimes intensified, social stigma. GLP-1 drugs like Ozempic and Wegovy have rapidly transformed weight loss from a frustrating, often futile struggle into something that,
scitechdaily.com
May 6, 2026 at 4:04 AM
Weight-Loss Drugs Like Ozempic May Come With an Unexpected Cost #Science #HealthandMedicine #PublicHealth #WeightLoss #HealthRisks #MedicationImpact
https://scitechdaily.com/weight-loss-drugs-like-ozempic-may-come-with-an-unexpected-cost/
https://scitechdaily.com/weight-loss-drugs-like-ozempic-may-come-with-an-unexpected-cost/